WARD-COPD: Wireless Assessment of Respiratory and Circulatory Distress in Chronic Obstructive Pulmonary Disease
Prospective observational study
Adult (>18 years) patients admitted with acute exacerbation of COPD (admission diagnosis)
Included patients are monitored with WARD equipment from admission and up to 4 days forward during hospitalization.
Severe adverse events (SAE’s) at 30 days and 6 months after study inclusion.
Mikkel Elvekjær, MD, PhD student